Myelofibrosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
Myelofibrosis was first discribed by Gustav Heuck, a German surgeon, in 1879.<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | *Myelofibrosis was first discribed by Gustav Heuck, a German surgeon, in 1879.<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | ||
*The concept of myeloproliferative disorders (MPDs) was described by William Dameshek, in 1951, by bringing together [[chronic myelogenous leukemia]] (CML), [[polycythemia vera]] (PV), [[essential thrombocythemi]]a (ET), primary myelofibrosis (PMF), and [[erythroleukemia]].<ref name="Tefferi2007">{{cite journal|last1=Tefferi|first1=A|title=The history of myeloproliferative disorders: before and after Dameshek|journal=Leukemia|volume=22|issue=1|year=2007|pages=3–13|issn=0887-6924|doi=10.1038/sj.leu.2404946}}</ref> | |||
==References== | ==References== | ||
Revision as of 20:04, 7 March 2016
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis historical perspective |
|
Risk calculators and risk factors for Myelofibrosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Myelofibrosis was first discribed by Gustav Heuck, a German surgeon, in 1879.[1]
Historical Perspective
- Myelofibrosis was first discribed by Gustav Heuck, a German surgeon, in 1879.[1]
- The concept of myeloproliferative disorders (MPDs) was described by William Dameshek, in 1951, by bringing together chronic myelogenous leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), and erythroleukemia.[1]